Smurfit Westrock posts Q3 growth with $8.00B sales and $0.47 EPS
Smurfit Westrock plc reported Q3 2025 results reflecting post‑merger scale and ongoing integration. Net sales were $8,003 million, operating profit $526 million, and net income $246 million, or diluted EPS of $0.47. This compares with Q3 2024 net sales of $7,671 million and a net loss of $150 million.
For the first nine months of 2025, net sales were $23,599 million with operating profit of $1,330 million and net income of $602 million. Cash from operations reached $2,197 million, funding capital expenditures of $1,609 million and cash dividends of $675 million.
The balance sheet shows total assets of $45,569 million, cash and cash equivalents of $851 million, total debt of $14,111 million (including $798 million current), and shareholders’ equity of $18,433 million. Q3 included $65 million of impairment and $7 million of restructuring costs; year‑to‑date these totaled $360 million and $118 million, respectively, tied in part to facility closures announced in April 2025. The company expects $39 million of additional closure‑related charges through 2026. As of October 31, 2025, shares outstanding were 522,186,327.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What were Smurfit Westrock (SW) Q3 2025 sales and earnings?
How did nine-month 2025 results look for SW?
What cash flow did SW generate and how was it used?
What is Smurfit Westrock’s debt and liquidity position?
What restructuring and impairment charges did SW record?
What facility closures has SW announced?
How many SW shares are outstanding?
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company | |||
Page | |
EXPLANATORY NOTE | 3 |
PART I - FINANCIAL INFORMATION | 6 |
Item 1. Financial Statements | 6 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 37 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 51 |
Item 4. Controls and Procedures | 51 |
PART II - OTHER INFORMATION | 53 |
Item 1. Legal Proceedings | 53 |
Item 1A. Risk Factors | 53 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 53 |
Item 3. Defaults Upon Senior Securities | 53 |
Item 4. Mine Safety Disclosures | 53 |
Item 5. Other Information | 53 |
Item 6. Exhibits | 54 |
Signatures | 55 |
Page | |
Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 | 7 |
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and September 30, 2024 | 8 |
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and September 30, 2024 | 9 |
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and September 30, 2024 | 10 |
Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2025 and September 30, 2024 | 11 |
Notes to Condensed Consolidated Financial Statements | 14 |
September 30, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ million and $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 16) | |||
Equity: | |||
Preferred stock; $ | |||
Common stock; $ shares outstanding at September 30, 2025 and December 31, 2024, respectively | |||
Deferred shares; € September 30, 2025 and December 31, 2024, respectively | |||
Treasury stock; at cost; December 31, 2024, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $ | $ | $ | $ | |||
Cost of goods sold | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||
Impairment and restructuring costs | ( | ( | ( | ( | |||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Operating profit | |||||||
Pension and other postretirement non-service income (expense), net | ( | ||||||
Interest expense, net | ( | ( | ( | ( | |||
Other expense, net | ( | ( | ( | ( | |||
Income (loss) before income taxes | ( | ||||||
Income tax expense | ( | ( | ( | ( | |||
Net income (loss) | ( | ||||||
Net loss attributable to noncontrolling interests | |||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net income (loss) | $ | $( | $ | $ | |||
Other comprehensive income (loss), net of tax: | |||||||
Foreign currency translation gain (loss) | ( | ||||||
Defined benefit pension and other postretirement benefit plans adjustments | ( | ( | |||||
Net gain (loss) on cash flow hedges | ( | ||||||
Other comprehensive income (loss), net of tax | ( | ||||||
Comprehensive income (loss) | ( | ||||||
Comprehensive loss attributable to noncontrolling interests | |||||||
Comprehensive income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Nine months ended September 30, | |||
2025 | 2024 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment charges | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | |||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | |||
Accrued liabilities and other | |||
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | ( | ( | |
Other debt (repayments) additions, net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Tax paid in connection with shares withheld from employees | ( | ( | |
Purchases of treasury stock | ( | ||
Cash dividends paid to shareholders | ( | ( | |
Other | ( | ||
Net cash (used for) provided by financing activities | ( | ||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest ("NCI") | Total | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income (loss) | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at June 30, 2024(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net loss | — | — | — | — | ( | — | ( | — | ( |
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock restricted stock units and stock options attributable to pre-Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | ( | — | ( | |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income (loss) | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of deferred shares by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2023(1) | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Purchases of treasury stock | — | — | — | ( | — | — | ( | — | ( |
Shares of Smurfit Westrock common stock issued to WestRock shareholders and NCI assumed as a result of the Merger | — | — | — | ||||||
Converted WestRock restricted stock units and stock options attributable to pre-Combination services | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | ( | — | ( | |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2024 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended | Nine months ended | ||
September 30, 2024 | September 30, 2024 | ||
Net sales | $ | $ | |
Net income attributable to common shareholders |
Three months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended September 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Loss before income taxes | $( |
Nine months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Nine months ended September 30, 2024 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Amortization of fair value step up on inventory | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service expense, net | ( | ||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | |||||||
Income before income taxes | $ |
Nine months ended September 30, | |||
2025 | 2024 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate | |||
Total capital expenditures | $ | $ | |
September 30, | December 31, | ||
2025 | 2024 | ||
Assets: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total reportable segments | |||
Corporate(1) | |||
Total assets | $ | $ |
Three months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2024 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment charges | $ | $ | $ | $ | |||
Restructuring costs | |||||||
Impairment and restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Impairment of property, plant and equipment | $ | $ | $ | $ | |||
Impairment of other assets | |||||||
Total impairment charges | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | |||||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Severance charges | $ | $ | $ | $ | |||
Other costs | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
Severance charges | Other costs | Total | |||
Balance at December 31, 2024 | $ | $ | $ | ||
Charges for the period | |||||
Payments | ( | ( | ( | ||
Balance at September 30, 2025 | $ | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Transaction-related expenses associated with the Combination | $ | $( | $ | $( | |||
Integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Total transaction and integration-related expenses associated with the Combination | $( | $( | $( | $( | |||
September 30, | December 31, | ||
2025 | 2024 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable, net | $ | $ |
September 30, | December 31, | ||
2025 | 2024 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
September 30, | December 31, | ||
2025 | 2024 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Interest expense | $( | $( | $( | $( | |||
Interest income | |||||||
Interest expense, net | $( | $( | $( | $( | |||
September 30, 2025 | December 31, 2024 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Level 1 | Level 2 | ||||||
September 30, | December 31, | September 30, | December 31, | ||||
2025 | 2024 | 2025 | 2024 | ||||
Assets | |||||||
Other Investments: | |||||||
Listed | $ | $ | $ | $ | |||
Unlisted | |||||||
Derivatives in cash flow hedging relationships | |||||||
Derivatives not designated as hedging instruments | |||||||
Assets measured at fair value | $ | $ | $ | $ | |||
Liabilities | |||||||
Derivatives in cash flow hedging relationships | $ | $ | $ | $ | |||
Derivatives not designated as hedging instruments | |||||||
Liabilities measured at fair value | $ | $ | $ | $ | |||
Nine months ended September 30, | |||
2025 | 2024 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash (payments to) proceeds from financial institutions | ( | ||
Receivable from financial institutions at September 30 | $ | $ | |
September 30, | December 31, | ||
2025 | 2024 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Term loan facilities | |||
Bank loans | |||
Finance lease obligations | |||
Bank overdrafts | |||
Total debt, excluding debt issuance costs | |||
Debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | Defined Benefit Pension Plans | ||||||||||||||
U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | ||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest cost | |||||||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | ( | ( | |||||||
Amortization of: | |||||||||||||||
Net actuarial loss | |||||||||||||||
Prior service credit | ( | ( | ( | ||||||||||||
Settlement loss | |||||||||||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | $( | $( | $ | $ | |||||||
Other Postretirement Benefit Plans | Other Postretirement Benefit Plans | ||||||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Amortization of: | |||||||
Net actuarial loss | ( | ( | |||||
Net periodic benefit cost | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Numerator: | |||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Denominator: | |||||||
Basic weighted average shares outstanding | |||||||
Effect of dilutive share options | |||||||
Diluted weighted average shares outstanding | |||||||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Performance stock units | |||||||
Restricted stock units | |||||||
Total antidilutive shares | |||||||
September 30, | December 31, | ||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Reserves(1) | Total(2) | |
Balance at June 30, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at September 30, 2024 | $ | $ | $ | $( | $ |
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Other comprehensive income | ( | ( | ( | ( | |
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Reserves(1) | Total(2) | |
Balance at December 31, 2023 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at September 30, 2024 | $ | $ | $ | $( | $ |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Three months ended September 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain | $ | $ | $ | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | |||||||
Consolidated other comprehensive income | ( | ( | |||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income attributable to common shareholders | $ | $( | $ | $ | $( | $ | |
Nine months ended September 30, | |||||||
2025 | 2024 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain (loss) | $ | $ | $ | $( | $ | $( | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Net actuarial loss arising during period | ( | ( | ( | ( | |||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Amortization of prior service credit | ( | ( | ( | ( | |||
Foreign currency loss - pensions | ( | ( | ( | ( | |||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income (loss) | ( | ( | ( | ||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income (loss) attributable to common shareholders | $ | $ | $ | $( | $( | $( | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $8,003 | $7,671 | $23,599 | $13,570 | |||
Cost of goods sold | (6,434) | (6,321) | (18,938) | (10,817) | |||
Gross profit | 1,569 | 1,350 | 4,661 | 2,753 | |||
Selling, general and administrative expenses | (963) | (1,007) | (2,899) | (1,776) | |||
Impairment and restructuring costs | (65) | (21) | (360) | (21) | |||
Transaction and integration-related expenses associated with the Combination | (15) | (267) | (72) | (350) | |||
Operating profit | 526 | 55 | 1,330 | 606 | |||
Pension and other postretirement non-service income (expense), net | 8 | 8 | 24 | (31) | |||
Interest expense, net | (177) | (167) | (526) | (225) | |||
Other expense, net | (21) | (13) | (44) | (13) | |||
Income (loss) before income taxes | 336 | (117) | 784 | 337 | |||
Income tax expense | (91) | (33) | (183) | (164) | |||
Net income (loss) | 245 | (150) | 601 | 173 | |||
Net loss attributable to noncontrolling interests | 1 | — | 1 | — | |||
Net income (loss) attributable to common shareholders | $246 | $(150) | $602 | $173 | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales (aggregate):(1) | |||||||
North America | $4,721 | $4,649 | $14,145 | $5,499 | |||
Europe, MEA and APAC | 2,831 | 2,651 | 8,191 | 7,056 | |||
LATAM | 545 | 506 | 1,576 | 1,187 | |||
Segment Adjusted EBITDA: | |||||||
North America | $810 | $780 | $2,347 | $900 | |||
Europe, MEA and APAC | 419 | 411 | 1,180 | 1,158 | |||
LATAM | 116 | 116 | 354 | 257 | |||
Nine months ended September 30, | |||
2025 | 2024 | ||
Net cash provided by operating activities | $2,197 | $702 | |
Net cash used for investing activities | $(1,564) | $(1,595) | |
Net cash (used for) provided by financing activities | $(674) | $869 | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net income (loss) | $245 | $(150) | $601 | $173 | |||
Income tax expense | 91 | 33 | 183 | 164 | |||
Depreciation, depletion and amortization | 659 | 564 | 1,875 | 872 | |||
Impairment and restructuring costs | 65 | 21 | 360 | 21 | |||
Transaction and integration-related expenses associated with the Combination | 15 | 267 | 72 | 350 | |||
Amortization of fair value step up on inventory | — | 227 | — | 227 | |||
Interest expense, net | 177 | 167 | 526 | 225 | |||
Pension and other postretirement non-service (income) expense, net | (8) | (8) | (24) | 31 | |||
Share-based compensation expense | 35 | 123 | 114 | 154 | |||
Other expense, net | 21 | 13 | 44 | 13 | |||
Other adjustments | 2 | 8 | 16 | (10) | |||
Adjusted EBITDA | $1,302 | $1,265 | $3,767 | $2,220 | |||
SUMMARIZED STATEMENT OF OPERATIONS | Nine months ended September 30, |
2025 | |
Net sales to unrelated parties | $1,100 |
Net sales to Non-Obligor Subsidiaries | 909 |
Gross profit | 697 |
Interest expense, net with unrelated parties | (464) |
Interest expense, net with Non-Obligor Subsidiaries | (253) |
Net income and net income attributable to the Obligor Group | 291 |
SUMMARIZED BALANCE SHEETS | September 30, | December 31, | |
2025 | 2024 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $5,617 | $4,925 | |
Other current assets | 920 | 1,049 | |
Total current assets | $6,537 | $5,974 | |
Non-current amounts due from Non-Obligor Subsidiaries | $2,938 | $2,848 | |
Other non-current assets | 384 | 370 | |
Total non-current assets | $3,322 | $3,218 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $8,320 | $9,681 | |
Other current liabilities | 999 | 1,122 | |
Total current liabilities | $9,319 | $10,803 | |
Non-current amounts due to Non-Obligor Subsidiaries | $6,467 | $6,604 | |
Other non-current liabilities | 11,683 | 9,644 | |
Total non-current liabilities | $18,150 | $16,248 |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||
July 1, 2025 – July 31, 2025 | 822 | $43.00 | — | — | |||
August 1, 2025 – August 31, 2025 | — | — | — | — | |||
September 1, 2025 – September 30, 2025 | — | — | — | — | |||
Total | 822 | — |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
10.1†+ | Second Amendment to Purchasing and Servicing of Receivables, dated as of September 12, 2025, among WestRock Company, various WestRock Company subsidiaries, and Coöperatieve Rabobank, U.A. | ||
22 | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 of the Company’s Quarterly Report on Form 10-Q filed on August 7, 2025). | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: November 7, 2025 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: November 7, 2025 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Group Chief Financial Officer | |
(Principal Financial Officer) | ||